1. Home
  2. CCS vs ZYME Comparison

CCS vs ZYME Comparison

Compare CCS & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Communities Inc.

CCS

Century Communities Inc.

HOLD

Current Price

$62.57

Market Cap

2.0B

ML Signal

HOLD

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$26.56

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCS
ZYME
Founded
2000
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
CCS
ZYME
Price
$62.57
$26.56
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $64.80
$38.90
AVG Volume (30 Days)
221.6K
★ 514.3K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
★ 2.31%
N/A
EPS Growth
N/A
★ 33.33
EPS
★ 2.09
N/A
Revenue
★ $4,117,816,000.00
$105,965,000.00
Revenue This Year
N/A
$183.10
Revenue Next Year
$10.84
N/A
P/E Ratio
$29.67
★ N/A
Revenue Growth
N/A
★ 38.87
52 Week Low
$47.28
$16.00
52 Week High
$76.00
$31.34

Technical Indicators

Market Signals
Indicator
CCS
ZYME
Relative Strength Index (RSI) 45.52 47.51
Support Level $57.96 $22.10
Resistance Level $65.78 $27.30
Average True Range (ATR) 1.68 0.99
MACD 0.25 -0.19
Stochastic Oscillator 65.49 24.20

Price Performance

Historical Comparison
CCS
ZYME

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing and sale of single-family attached and detached homes. The company builds and sells homes under its Century Communities and Century Complete brands. Its reportable segments for homebuilding operations are: i) West (California and Washington) ii) Mountain (Arizona, Colorado, Nevada and Utah), iii) Texas, iv) Southeast (Florida, Georgia, North Carolina, South Carolina and Tennessee), v) Century Complete (Alabama, Arizona, Florida, Georgia, Indiana, Kentucky, Michigan, North Carolina, and South Carolina). The company's other reportable segments include: Financial Services and Century Living. The company derives the majority of its revenue from the sale of new homes in the Mountain segment.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: